The increasing interest in effective weight management has spurred considerable investigation into cutting-edge treatments. Currently, Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activator , has shown encouraging resul